questionText: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that off-label prescriptions of Ozempic Semaglutide for weight-loss from private healthcare providers do not create supply shortages for those prescrib
answerText: We have issued guidance in the form of Medicine Supply Notifications and, on 18 July, issued a National Patient Safety Alert which made it clear that Ozempic, which is solely licensed to treat type 2 diabetes, should only be used for that purpose, and sho...
heading: Semaglutide